John J. Harrington
Net Worth
Last updated:
What is John J. Harrington net worth?
The estimated net worth of Dr. John J. Harrington is at least $9,754,214 as of 17 Sep 2021. He owns shares worth $19,005 as insider, has earned $642,589 from insider trading and has received compensation worth at least $9,092,620 in Athersys, Inc..
What is the salary of John J. Harrington?
Dr. John J. Harrington salary is $534,860 per year as Co-Founder, Chief Scientific Officer, Executive Vice President & Director in Athersys, Inc..
How old is John J. Harrington?
Dr. John J. Harrington is 58 years old, born in 1967.
What stocks does John J. Harrington currently own?
As insider, Dr. John J. Harrington owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Athersys, Inc. (ATHX) | Co-Founder, Chief Scientific Officer, Executive Vice President & Director | 730,960 | $0.03 | $19,005 |
What does Athersys, Inc. do?
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.
John J. Harrington insider trading
Athersys, Inc.
Dr. John J. Harrington has made 50 insider trades between 2008-2021, according to the Form 4 filled with the SEC. Most recently he sold 11,981 units of ATHX stock worth $17,612 on 17 Sep 2021.
The largest trade he's ever made was exercising 30,000 units of ATHX stock on 20 Sep 2013. As of 17 Sep 2021 he still owns at least 730,960 units of ATHX stock.
Athersys key executives
Athersys, Inc. executives and other stock owners filed with the SEC:
- Dr. John J. Harrington (58) Co-Founder, Chief Scientific Officer, Executive Vice President & Director
- Mr. Ivor Macleod CPA, M.B.A. (63) Chief Financial Officer & Principal Accounting Officer
- Mr. William B. J. Lehmann Jr., M.B.A., J.D., MBA (59) Pres, Chief Operating Officer, Sec. & Interim Chief Executive Officer